Skip to content
  • About
  • Shop
  • News
  • Contact Us
Search
NECA Logo
  • NET Nurse
  • Donate
  • What are NETs?
    • What are Neuroendocrine Cancers?
    • What are Pheos & Paras?
    • NET Symptoms
    • NET Types
    • Causes
    • Treatments
    • Grades
    • Diagnosis
    • Prognosis
    Consider the Grey Area
  • Patients & Carers
    • Patient & Carer Support
    • Patient Resources
    • Optimal Care Pathway
    • NET Nurse
    • Patient Stories
    • Share your Story
    • Australian NET Specialists
    • Clinical Trials
    • Living with NETS
    • Specialist Support Services
    Consider the Grey Area
  • Healthcare Professionals
    • Optimal Care Pathway
    • Professional Learning
    • Patient Referral
    • Clinical Trials
    • NET Symptoms
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order Booklets & Resources
    Consider the Grey Area
  • Get Involved
    • Advocate for Us
    • Share your Story
    • Donate
    • Fundraise
    • Events
    • In Memoriam
    • Corporate Partners
    • Gifts & Wills
    • Volunteer
    Senate MailChimp
  • NCD 2025
NET Nurse
Donate

Home » Advocacy » INCA launches global survey for NET patients and HCPs

INCA launches global survey for NET patients and HCPs

  • September 24, 2019

In order to better understand the challenges to provision of optimal care to NET patients, INCA is launching SCAN – a global survey designed to capture both NET patients’ and healthcare professionals’ perspectives, which went live on September 16th.

SCAN is an acronym standing for Survey of Challenges in Access to Diagnostics and Treatment for NET Patients. It aims to collect robust global data by geographical areas covering Africa, Asia, Oceania, North and South America reflective of the NET patients and the medical communities with relevance to NETs. The survey will be available in 14 languages: Arabic, Bulgarian, Chinese, Dutch/Flemish, French, English, German, Hindi, Japanese, Italian, Portuguese, Russian, Spanish, and Swahili.

For the first time ever, SCAN is going to measure the out-of-pocket costs of diagnosis, treatment and on-going monitoring of NETs on a global scale. You can read more on the survey’s aims here.

INCA invites medical professionals from the fields of medical oncology, endocrinology, gastroenterology, pathology, nuclear medicine, surgery, as well as general practitioners and nurses to share their viewpoints.

With the ambitious goal of collecting responses from all parts of the world, we turn to you with a special request to help spread the word about SCAN.

The survey for Healthcare Professionals can be found here (your responses and time are invaluable).

The survey for NET patients and NET patient caregivers is available here (we ask our patients and carergivers to complete this survey and health professionals to send to as many patients as possible).

Given the significant outreach potential and influence of Australians, your support would mean a lot for increasing the impact of SCAN. We will be grateful if you could help us in achieving maximum coverage by disseminating the survey to your members and partners. In terms of timelines, SCAN field phase is scheduled to take place from September 16th until October 31st.

Thank you in advance for supporting our efforts to improve outcomes for NET patients.

Share this post

Recent posts

Rare Cancers Roundtable

September 26, 2025

Shining a Light for World Neuroendocrine Cancer Day – Help Us Light Up Australia

September 26, 2025

Celebrating Shane Kent’s Arch2Arc Journey and Fundraising

September 20, 2025

Will Norman Nurse Webinar on Neuroendocrine Cancer

September 19, 2025
Categories
  • Advocacy
  • Awareness
  • Community Events
  • Education
  • Events
  • Fundraising
  • General
  • In The Media
  • News
  • Research
  • Unicorn Events
PrevPreviousCanberra NET Patient Forum
NextWorld NET Cancer Day 2019Next

Related Posts

PCPA Cancer Summit

  The Private Cancer Physicians of Australia (PCPA) hosted its Annual Meeting: Cancer Summit 2025 in Sydney on 13 September, bringing together clinicians, researchers, and

SCAN 2025 is now open – we need your voice

SCAN 2025 is now open – we need your voice.  As a proud member of the International Neuroendocrine Cancer Alliance (INCA), NeuroEndocrine Cancer Australia is excited

Medicines Australia Horizon Scanning – Advancing Patient Access and Genomics

NeuroEndocrine Cancer Australia CEO Meredith Cummins joined a panel discussion at the Medicines Australia Horizon Scanning event, accompanied by Media and External Relations Manager Ciara

CanForum 2025: Now it’s personal: Access and equity for all

On 2nd September 2025, NeuroEndocrine Cancer Australia CEO Meredith Cummins and Media and External Relations Manager Ciara Connolly attended CanForum 2025, a leading national conference

View All

Subscribe to Newsletter

NECA Logo
registered charity badge

What are NETs

  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies
  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies

Patients & Carers

  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library
  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library

Healthcare Professionals

  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials
  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials

Get Involved

  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
All charity donations to NeuroEndocrine Cancer Australia may be tax-deductible in Australia.

Registered Charity CFN 202607
© 2025 NeuroEndocrine Cancer Australia
  • Website by Five Creative
Twitter Facebook Youtube Instagram Linkedin